Phase 1 Open-Label Study Of Ladiratuzumab Vedotin In Patients With First-Line Unresectable Locally Advanced Or Metastatic Triple-Negative Breast Cancer (Sgnlva-001, Part F, Trial In Progress)
Ladiratuzumab Vedotin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1 Open-Label Study Of Ladiratuzumab Vedotin In Patients With First-Line Unresectable Locally Advanced Or Metastatic Triple-Negative Breast Cancer (Sgnlva-001, Part F, Trial In Progress) ### Output: Ladiratuzumab Vedotin